These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging. Poon DT; Li G; Aldovini A J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052 [TBL] [Abstract][Full Text] [Related]
23. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Lopez-Vergès S; Camus G; Blot G; Beauvoir R; Benarous R; Berlioz-Torrent C Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14947-52. PubMed ID: 17003132 [TBL] [Abstract][Full Text] [Related]
24. In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein. Manrique JM; Affranchino JL; González SA Virology; 2008 May; 374(2):273-9. PubMed ID: 18255119 [TBL] [Abstract][Full Text] [Related]
25. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain. Liao WH; Wang CT Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885 [TBL] [Abstract][Full Text] [Related]
26. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. Dorfman T; Mammano F; Haseltine WA; Göttlinger HG J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229 [TBL] [Abstract][Full Text] [Related]
27. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. Yu X; Yu QC; Lee TH; Essex M J Virol; 1992 Sep; 66(9):5667-70. PubMed ID: 1501299 [TBL] [Abstract][Full Text] [Related]
28. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. Wang CT; Zhang Y; McDermott J; Barklis E J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966 [TBL] [Abstract][Full Text] [Related]
29. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. Sova P; Volsky DJ; Wang L; Chao W J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958 [TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. Chazal N; Gay B; Carrière C; Tournier J; Boulanger P J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731 [TBL] [Abstract][Full Text] [Related]
31. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960 [TBL] [Abstract][Full Text] [Related]
32. Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions. Deminie CA; Emerman M J Virol; 1993 Nov; 67(11):6499-506. PubMed ID: 8411353 [TBL] [Abstract][Full Text] [Related]
33. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672 [TBL] [Abstract][Full Text] [Related]
34. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252 [TBL] [Abstract][Full Text] [Related]
35. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles. Chiu HC; Yao SY; Wang CT J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546 [TBL] [Abstract][Full Text] [Related]
36. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. Cimarelli A; Luban J J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286 [TBL] [Abstract][Full Text] [Related]
37. Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication. Kaushik R; Ratner L J Virol; 2004 Mar; 78(5):2319-26. PubMed ID: 14963128 [TBL] [Abstract][Full Text] [Related]
38. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. Murakami T; Freed EO J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129 [TBL] [Abstract][Full Text] [Related]
39. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865 [TBL] [Abstract][Full Text] [Related]
40. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. Davis MR; Jiang J; Zhou J; Freed EO; Aiken C J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]